Brief: GenScript Announces Notice Of Allowance For U.S. Patent Application For SARS-CoV-2 Surrogate Virus Neutralization Kit
28/07/2021 12:54
July 28 (Reuters) - GenScript Biotech Corp 1548.HK :
* GENSCRIPT ANNOUNCES NOTICE OF ALLOWANCE FOR U.S. PATENT
APPLICATION FOR SARS-COV-2 SURROGATE VIRUS NEUTRALIZATION KIT
Source text for Eikon: ID:nPnbNNrnKa
Further company coverage: 1548.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genscript Biotech
See all newsBrief: Genscript Launches Life Sciences Startup Pitchfest With Nvidia For Biotech Innovation
GenScript Biotech extends gain to hit near 5-year peak on Eli Lilly deal
GenScript Biotech hits near 5-year high on Eli Lilly collaboration
Brief: ProBio & Kun Tuo Announce Strategic Collaboration To Deliver Integrated CDMO-CRO Solutions
HK-listed GenScript Biotech drops on discounted share sale